Skip to content

Latest News on COVID 19 for You; Revised Labor and Delivery Guidelines

GIVE NOW
1-844-HMH-WELL

Find a Doctor
About
Location
Team
Services
Research
Resources
Donate

Contact us

Clinical Trials

Home › Clinical Trials › Pediatrics › Rheumatology › Validation of Pediatric Patient Reported Outcomes in Chronic Diseases

Validation of Pediatric Patient Reported Outcomes in Chronic Diseases

Research Study Number:
Pro00005835c

Short Title:
CARRA Registry-PEPR

Division:
Rheumatology

Study Status:
Enrolling

Post navigation

View all types of trials

Conditions / Diseases

All
Bone Marrow Transplant
Endocrine
Genetics
Nephrology
Neuro-Oncology
Oncology
Rheumatology

Recently Added Trials

Phase 3 Study of Ibrutinib in Combination with Venetoclax in Subjects with Mantle Cell Lymphoma
MERCK MK7902-001-01 A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma (LEAP-001)
IST-2015-100730-Phase I Study of Carfilzomib-based Chemotherapy mobilization for autologous stem cell transplantation in multiple Myeloma
A Phase II, Randomized, Open-label Platform Study of Novel Regimens Versus Standard of Care Treatment in NSCLC Participants
A Phase 1b-2 Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Erdafitinib plus JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Subjects with Metastatic or Surgically Unresectable Urothelial Cancer with Selected FGFR Gene Alterations

© 2020 Hackensack Meridian Health

About Us
Careers
Classes & Events
Contact Us
Financial Practices
Patients & Visitors
Privacy
Terms & Conditions